Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio…
DFJ Growth's Justin Kao Joins Delfi Board of Directors
Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible…